Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.52 |
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.52 |
| ▸ | DRD2 | P14416 | 2/20 | 0.50 |
| ▸ | DRD3 | P35462 | 2/20 | 0.50 |
| ▸ | USP2 | O75604 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.38 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.38 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10109539 | 0.93 | MEN1 (0.49) | KMT2AMEN1SLC18A3DRD2DRD3 | |
| SCHEMBL24319428 | 0.91 | KDM4E (0.53) | KMT2AMEN1SLC18A3DRD2DRD3 | |
| SCHEMBL10678924 | 0.91 | KDM4E (0.53) | KMT2AMEN1SLC18A3DRD2DRD3 | |
| SCHEMBL19044554 | 0.91 | KDM4E (0.53) | KMT2AMEN1SLC18A3DRD2DRD3 | |
| SCHEMBL2489189 | 0.90 | KMT2A (0.68) | KMT2AMEN1SLC18A3DRD2DRD3 | |
| SCHEMBL11892695 | 0.90 | — | — | |
| SCHEMBL11892772 | 0.90 | — | — | |
| SCHEMBL19090254 | 0.90 | KMT2A (0.68) | KMT2AMEN1SLC18A3DRD2DRD3 | |
| SCHEMBL2489191 | 0.90 | KMT2A (0.68) | KMT2AMEN1SLC18A3DRD2DRD3 | |
| SCHEMBL24672708 | 0.89 | SLC18A3 (0.45) | KMT2AMEN1SLC18A3DRD2DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119775226-A | Foaming catalyst for producing polyurethane foam, and preparation method and application thereof | 武汉大学 | 2025-04-08 | — | — | CN | disclosed |
| CN-105153068-A | Product containing epichlorohydrin, its preparation and its use in various applications | SOLVAY | 2015-12-16 | — | — | CN | disclosed |
| US-20130190474-A1 | EPICHLOROHYDRIN, MANUFACTURING PROCESS AND USE | SOLVAY SA (BE) | 2013-07-25 | — | — | US | disclosed |
| US-20130102755-A1 | PRODUCT CONTAINING EPICHLOROHYDRIN, ITS PREPARATION AND ITS USE IN VARIOUS APPLICATIONS | SOLVAY SA (BE) | 2013-04-25 | — | — | US | disclosed |
| US-8399692-B2 | Epichlorohydrin, manufacturing process and use | SOLVAY (SOCIETE ANONYME) (BE) | 2013-03-19 | — | — | US | disclosed |
| US-8378130-B2 | Product containing epichlorohydrin, its preparation and its use in various applications | SOLVAY (SOCIETE ANONYME) (BE) | 2013-02-19 | — | — | US | disclosed |
| US-20100179300-A1 | Product containing epichlorohydrin, its preparation and its use in various applications | SOLVAY (SOCIETE ANONYME) (BE) | 2010-07-15 | — | — | US | disclosed |
| US-20100168379-A1 | Epichlorohydrin, manufacturing process and use | SOLVAY (SOCIETE ANONYME) (BE) | 2010-07-01 | — | — | US | disclosed |
| US-20100022559-A1 | BISOXIMES AS FUNGICIDES | BAYER CROPSCIENCE AG (DE) | 2010-01-28 | — | — | US | disclosed |
| EP-1280880-B1 | LAUNDRY DETERGENT COMPOSITIONS CONTAINING A POLYMER | PROCTER & GAMBLE (US) | 2008-10-29 | — | — | EP | disclosed |
| EP-1325107-A1 | LAUNDERING AID FOR PREVENTING DYE TRANSFER | The Procter & Gamble Company (US) | 2003-07-09 | — | — | EP | disclosed |
| US-20030118730-A1 | Method for manufacturing laundry additive article | PROCTER & GAMBLE COMPANY, THE | 2003-06-26 | — | — | US | disclosed |
| US-20030078185-A1 | Polyelectrolyte complexes and a method for production thereof | BASF AKTIENGESELLSCHAFT (DE) | 2003-04-24 | — | — | US | disclosed |
| EP-1280880-A2 | LAUNDRY DETERGENT COMPOSITIONS CONTAINING A POLYMER | THE PROCTER & GAMBLE COMPANY (US) | 2003-02-05 | — | — | EP | disclosed |
| WO-2002033040-A1 | LAUNDERING AID FOR PREVENTING DYE TRANSFER | THE PROCTER & GAMBLE COMPANY (US) | 2002-04-25 | — | — | WO | disclosed |
| US-20010056058-A1 | Laundry detergent compositions containing a polymer for fabric appearance improvement | THE PROCTER & GAMBLE COMPANY | 2001-12-27 | — | — | US | disclosed |
| WO-2001085891-A2 | LAUNDRY DETERGENT COMPOSITIONS CONTAINING A POLYMER | THE PROCTER & GAMBLE COMPANY (US) | 2001-11-15 | — | — | WO | disclosed |
| US-6147183-A | Amphoteric amine based polymers having a net cationic charge and process for their production | BASF AKTIENGESELLSCHAFT (DE) | 2000-11-14 | — | — | US | disclosed |
| US-6111056-A | Cyclic amine based polymers and process for their production | BASF AKTIENGESELLSCHAFT (DE) | 2000-08-29 | — | — | US | disclosed |
| US-4964875-A | Process for after-treatment of dyed polyamide textile materials with polyurethane containing quaternary ammonium groups | BAYER AKTIENGESELLSCHAFT (DE) | 1990-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100022559-A1 | BISOXIMES AS FUNGICIDES | DDT, FHIT, CYP4X1 | KMT2A 900/4885MEN1 675/4885SLC18A3 4371/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.